<DOC>
	<DOCNO>NCT00469170</DOCNO>
	<brief_summary>The propose study multi-centre , open-label crossover study assess safety acceptability silicone elastomer vaginal ring ( contain drug ) insert 12 week period 200 healthy , sexually active woman .</brief_summary>
	<brief_title>A Safety Acceptability Study Vaginal Ring Microbicide Delivery Method</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Female , age 1835 year Willing able provide write informed consent HIVuninfected otherwise healthy Selfreported sexually active On stable hormonal contraceptive regimen Regular menstrual cycle Willing refrain use vaginal product object study Currently pregnant last pregnancy within 3 month prior enrollment Currently breastfeed Participated research study within 30 day prior enrollment ; Symptomatic untreated vaginal infection within 2 week prior enrollment Presence abnormal physical finding vulva , vaginal wall cervix History significant urogenital uterine prolapse , undiagnosed vaginal bleeding , urethral obstruction ; Pap smear result screening require cryotherapy , biopsy , treatment ( infection ) , evaluation Unexplained , undiagnosed abnormal bleeding per vagina , bleed per vagina follow vaginal intercourse , gynecologic surgery within 90 day prior enrollment Any serious acute , chronic progressive disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>HIV seronegativity</keyword>
</DOC>